$12.92
-0.01-0.08%
At close: Dec 15, 4:00 PM EST
$12.92
N/A
After Hours: 4:03 PM EST
Comments
Loading...
Astria Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ATXS | Benzinga
Astria Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 10
EPS Estimate
$-0.490
Quarterly Revenue Estimate
$1.04M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$706.00K
Analyze the earnings history of Astria Therapeutics using advanced sorting and filters.
Astria Therapeutics (ATXS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-0.55 | $-0.42 | -30.9 % |
| Q2 | 2025-08-12 | $-0.57 | $-0.59 | 3.39 % |
| Q1 | 2025-05-13 | $-0.58 | $-0.48 | -20.8 % |
| Q4 | 2025-03-11 | $-0.44 | $-0.45 | 2.22 % |
Astria Therapeutics (ATXS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $706.00K | $12.80M | -94.5 % |
FAQ
When is Astria Therapeutics (NASDAQ:ATXS) reporting earnings?
Astria Therapeutics (ATXS) is scheduled to report earnings on March 10, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for Astria Therapeutics (NASDAQ:ATXS)?
The Actual EPS was $-0.55, which missed the estimate of $-0.42.
What were Astria Therapeutics’s (NASDAQ:ATXS) revenues?
The Actual Revenue was $706K, which missed the estimate of $12.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
